Department of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792-3252, United States.
Department of Abdominal Imaging, MD Anderson Cancer Center, Houston, TX 77030-4009, United States.
Br J Radiol. 2024 Aug 1;97(1160):1431-1436. doi: 10.1093/bjr/tqae111.
Characterize the CT findings of abdominopelvic Castleman disease, including a new observation involving the perinodal fat.
Multi-centre search at 5 institutions yielded 76 adults (mean age, 42.1 ± 14.3 years; 38 women/38 men) meeting inclusion criteria of histopathologically proven Castleman disease with nodal involvement at abdominopelvic CT. Retrospective review of the dominant nodal mass was assessed for size, attenuation, and presence of calcification, and for prominence and soft-tissue infiltration of the perinodal fat. Hypervascular nodal enhancement was based on both subjective and objective comparison with aortic blood pool attenuation.
Abdominal involvement was unicentric in 48.7% (37/76) and multicentric in 51.3% (39/76), including 31 cases with extra-abdominal involvement. Histopathologic subtypes included hyaline vascular variant (HVV), plasma cell variant (PCV), mixed HVV/PCV, and HHV-8 variant in 39, 25, 3 and 9 cases, respectively. The dominant nodal mass measured 4.4 ± 1.9 cm and 3.2 ± 1.7 cm in mean long- and short-axis, respectively, and appeared hypervascular in 58.6% (41/70 with IV contrast). Internal calcification was seen in 22.4% (17/76). Infiltration of the perinodal fat, with or without hypertrophy, was present in 56.6% (43/76), more frequent with hypervascular vs non-hypervascular nodal masses (80.5% vs 20.7%; P < .001). Among HVV cases, 76.9% were unicentric, 71.1% appeared hypervascular, and 69.2% demonstrated perinodal fat infiltration.
Hypervascular nodal masses demonstrating prominence and infiltration of perinodal fat at CT can suggest the specific diagnosis of Castleman disease, especially the HVV.
Abdominopelvic nodal masses that demonstrate hypervascular enhancement and prominent infiltration of the perinodal fat at CT can suggest the diagnosis of Castleman disease, but nonetheless requires tissue sampling.
描述腹盆腔 Castleman 病的 CT 表现,包括一种新的与淋巴结周围脂肪相关的观察结果。
在 5 家机构进行了多中心搜索,共纳入 76 例经组织病理学证实的腹盆腔 CT 淋巴结受累的成人(平均年龄 42.1±14.3 岁;38 名女性/38 名男性)。回顾性评估主要淋巴结肿块的大小、衰减值、有无钙化,以及淋巴结周围脂肪的突出和软组织浸润情况。根据与主动脉血池衰减值的主观和客观比较,评估淋巴结的强化程度。
76 例患者中,48.7%(37/76)为局灶性病变,51.3%(39/76)为多灶性病变,包括 31 例合并腹外病变。组织病理学亚型包括透明血管型(HVV)、浆细胞型(PCV)、混合 HVV/PCV 和 HHV-8 型,分别为 39、25、3 和 9 例。主要淋巴结肿块的长轴和短轴平均直径分别为 4.4±1.9cm 和 3.2±1.7cm,58.6%(70 例中有 41 例接受 IV 造影)呈富血供表现。22.4%(76 例中有 17 例)可见内部钙化。淋巴结周围脂肪有或无肥大,56.6%(76 例中有 43 例)出现浸润,富血供与非富血供淋巴结肿块相比更常见(80.5%比 20.7%;P<.001)。在 HHV 病例中,76.9%为局灶性病变,71.1%呈富血供表现,69.2%表现为淋巴结周围脂肪浸润。
CT 显示富血供淋巴结肿块并突出、浸润淋巴结周围脂肪,提示 Castleman 病的特定诊断,特别是 HHV 型。
CT 显示富血供增强并突出、浸润淋巴结周围脂肪的腹盆腔淋巴结肿块可提示 Castleman 病的诊断,但仍需要组织取样。